Start typing to retrieve search suggestions. When suggestions are available use up and down arrows to review and ENTER to select. Continue typing to refine.
Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Remsima 120 mg solution for injection in pre-filled pen (green)

{email} Notify me of changes to this product

emc account functionality

Sign in or register for an emc account to use this functionality and much more:

  • Get the latest updates to your inbox

    Receive email notifications when chosen products are updated

  • Stay up to date with document change history

    Get full access to document change history

  • Similar product search

    Use active ingredient, company or ATC code

  • Save your regular searches

    Simple access to search enquiries every time you need them

  • Favourite products you use most often

    Helps you find products you use regularly as fast as possible

Active Ingredient:
infliximab
Company:  
Celltrion Healthcare UK Limited See contact details
ATC code: 
L04AB02
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) User Manual Risk Materials
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Remsima Patient alert card

Patient alert card

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Celltrion Healthcare UK Limited
Company image
Address
Celltrion Healthcare UK Limited, The Charter Building, Charter Place, Uxbridge, UB8 1JG, UK
WWW
http://www.celltrionhealthcare.co.uk/
Telephone
01753 983 500
Medical Information Direct Line
01753 983 500
Medical Information e-mail
[email protected]
Customer Care direct line
01753 983 500
Adverse event reporting email
[email protected]